Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
07/2010
07/21/2010CN101781642A Culture medium for identifying differential protein components in Trichoderma koningii cellulose system and application thereof
07/21/2010CN101781635A Plant cell having animal-type sugar chain adding function
07/21/2010CN101781368A Anti-amyloid beta antibodies and their use
07/21/2010CN101781367A Method for purifying human parathyroid hormone (1 to 34)
07/21/2010CN101781366A Novel antibacterial peptide and preparation method and application thereof
07/21/2010CN101781365A Artificial antigen of tetraodotoxin and corresponding specific antibody and preparation method and application thereof
07/21/2010CN101781364A Interleukin-1 receptor antagonist
07/21/2010CN101781363A Protein regulating development of plants and encoding gene and application thereof
07/21/2010CN101781362A Plant development associated protein, encoding gene and application thereof
07/21/2010CN101781361A Balsam pear MC-JJ2163 polypeptide analogs by microwave-enhanced solid-phase synthesis and application thereof
07/21/2010CN101781360A Recombinant rubella virus protein and application
07/21/2010CN101328481B Chrysalid pteromalid antibiotic protein Pp-AP3 and encoding nucleic acid sequence thereof
07/21/2010CN101234199B Hepatitis B and encephalitis B combined vaccine and preparation thereof
07/21/2010CN101177451B Micrococcus pyogenes adhesion functional peptide and coded sequence thereof
07/20/2010US7759563 Plants and seeds of corn variety CV875318
07/20/2010US7759477 Immunoglobulin for use in detection of simian and lymphadenopathy associated viral infection in mammals; immunodiagnostics
07/20/2010US7759476 Double-stranded RNAS directed to IKK-2
07/20/2010US7759474 used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 125P5C8 can be used in active or passive immunization
07/20/2010US7759467 increasing fficiency of transduction of hematopoietic cells; infecting cells in presence of fibronectin; stem cells; gene therapy; efficient retroviral infection of mammalian cells
07/20/2010US7759463 RNA interference pathway genes as tools for targeted genetic interference
07/20/2010US7759460 hair-binding peptide ; improved durability for long lasting effects and are easy and inexpensive to prepare
07/20/2010US7759314 Stabilizing collagen VI-deficient dystrophin-associated protein complexes (DAPCs) on the surface of a cell by contacting the cell with an effective amount of a biglycan therapeutic; treatment of muscular dystrophies
07/20/2010US7759309 Treating brain tissue injury or hemorrhagic shock by administering either a digested albumin that has been treated with trypsin and has an isoelectric point of higher than 4.8 and a molecular weight of less than 30 kpa, or a gelatin having an isoelectric point of 7-9 and a molecular weight of 1-10 kpa
07/20/2010US7759306 Methods of treating acute blood loss
07/20/2010US7759304 CR2-FH C-reactive protein, factor H fusion protein; inhibiting complement activation of the alternative pathway
07/20/2010US7759303 Method for improving solubility and folding efficiency of target proteins using RNA as molecular chaperone
07/20/2010US7759116 Dengue viruses useful for vaccination against Flavivirus; Modified Vaccinia Virus Ankara (MVA); stable, can easily be produced
07/20/2010US7759094 Method for the production of L-amino acids using strains from the Enterobacteriaceae family which contain an enhanced lamb gene
07/20/2010US7759091 Targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor; apoptosis-inducing factor
07/20/2010US7759082 Electroprocessed fibrin-based matrices and tissues
07/20/2010US7759078 Diagnosis and treatment of cancer
07/20/2010US7759066 identifying an inhibitor of an agonist to receptors CCR2 and/or CCR5 (chemokine C-C motif receptor); signal transduction system in the G protein relating signal transduction in the CCL2-CCR2 pathway
07/20/2010US7759059 Preparing DNA binding protein comprising multiple zinc finger domains for use in identifying modulators of protein-nucleic acid recognition; gene expression inhibition
07/20/2010US7758874 Genetic engineered polypeptides; bactericide
07/20/2010US7758865 Baculovirus expressing the exogenous nucleotide sequence porcine circovirus-B (PCVB) open reading frame 2; transformed host cells for expressing immunogenic protein for protecting pigs including pregnant pigs
07/20/2010US7758863 Replikin peptides in rapid replication of glioma cells and in influenza epidemics
07/20/2010US7758862 Hepatocyte growth factor receptor splice variants and methods of using same
07/20/2010US7758861 Are designed to produce both Type 1 and Type 2 phototherapeutic effect at once using dual wavelength light source that will produce singlet oxygen and free radicals at the lesion of interest; for dual phototherapy of tumors and other lesions
07/20/2010US7758858 Nucleotide sequences coding tumor necrosis factor binding proteins for prevention and treatment of bone disorders
07/20/2010US7758857 activating and administering human blood cells so that bone marrow histology and/or blood cell counts of patients suffering from a plastic anemia approach normal; culturing the blood cells in the presence of a cytokine and an ionophore
07/20/2010US7758855 DNA promoters and anthrax vaccines
07/20/2010US7758853 A protein obtainable from mouse liver, able to produce interferon- gamma by immunocompetent cells; producing antitumor agent
07/20/2010US7758852 OX40R binding agents
07/20/2010CA2655875C Detection of antibiotics
07/20/2010CA2487290C Ehd1 gene promoting plant flowering and utilization thereof
07/20/2010CA2421339C Novel polypeptides and nucleic acids encoding the same
07/20/2010CA2389250C Antibody catalysis of enantio- and diastereo-selective aldol reactions
07/20/2010CA2370519C Nucleic acids encoding a mutt domain-containing polypeptide
07/20/2010CA2349868C Cytochrome p450 monooxygenase and nadph cytochrome p450 oxidoreductase genes and proteins related to the omega hydroxylase complex of candida tropicalis and methods relating thereto
07/20/2010CA2309679C Method of identifying binding site domains that retain the capacity of binding to an epitope
07/20/2010CA2305864C Transgenic reduction of sinapine in crucifera
07/20/2010CA2289980C Prrsv antigenic sites identifying peptide sequences of prrs virus for use in vaccines or diagnostic assays
07/20/2010CA2278786C Selection of proteins using rna-protein fusions
07/20/2010CA2271249C Macromolecular neuraminidase-binding compounds
07/20/2010CA2246733C Use of a pharmaceutical composition comprising an appetite-suppressing peptide
07/20/2010CA2191063C Dna encoding glutamate gated chloride channels
07/20/2010CA2105449C An interferon-.alpha./.beta. binding protein, its preparation and pharmaceutical compositions containing it
07/15/2010WO2010081112A1 Prevention and/or treatment of multiple organ dysfunction syndrome with interleukin-22
07/15/2010WO2010081053A2 Transaminase polypeptides
07/15/2010WO2010081012A2 Disease control with tick phospholipase a2
07/15/2010WO2010081007A2 Carbonic anhydrase polypeptides and uses thereof
07/15/2010WO2010080994A2 Process for regulating immune response
07/15/2010WO2010080992A1 Regulators of the interferon-alpha receptor 1 (ifnar1) chain of the interferon receptor
07/15/2010WO2010080985A1 Compositions and methods for induced brown fat differentiation
07/15/2010WO2010080909A1 Compositions and methods of use of an oncolytic vesicular stomatitis virus
07/15/2010WO2010080836A2 Antibacterial and antifungal peptides
07/15/2010WO2010080804A1 Biomarkers and methods for determining sensitivity to epidermal growth factor receptor modulators
07/15/2010WO2010080506A1 Compositions and methods to prevent cancer with cupredoxins
07/15/2010WO2010080424A1 Peptide linkers for effective multivalent peptide binding
07/15/2010WO2010080065A1 Affinity chromatography matrix
07/15/2010WO2010080007A2 Lipoproteins derived from gram-positive bacteria functioning as toll-like receptor 2 ligand
07/15/2010WO2010079858A1 Novel bacteria-specific lysine proteins with broad antibacterial activity
07/15/2010WO2010079833A1 Novel cancer antigen eef2
07/15/2010WO2010079464A1 Cna_b domain antigens in vaccines against gram positive bacteria
07/15/2010WO2010079430A1 Modular dna-binding domains and methods of use
07/15/2010WO2010079383A2 Rice brown planthopper resistance gene and its application
07/15/2010WO2010079362A1 Complex and production process
07/15/2010WO2010079314A2 Novel polypeptides and use thereof
07/15/2010WO2010079286A1 Novel anti-ageing peptides, and cosmetic and/or pharmaceutical composition containing same
07/15/2010WO2010079285A1 Novel anti-ageing peptides and cosmetic and/or pharmaceutical composition containing same
07/15/2010WO2010079284A1 Novel anti-ageing peptides and cosmetic and/or pharmaceutical composition containing same
07/15/2010WO2010079230A1 Method for the selection of endothelial cells death inducers via netrin-1 and its applications
07/15/2010WO2010079156A1 Non-invasive tools for detecting vulnerable atherosclerotic plaques
07/15/2010WO2010078966A1 Fusion proteins forming trimers
07/15/2010WO2010078928A2 Specific and persistent activation of heat shock response in cell lines using a viral factor
07/15/2010WO2010078708A1 Nematicidal bacillus thuringiensis crystal protein gene cry1518-35
07/15/2010WO2010057985A3 Salmonella marker vaccine
07/15/2010WO2010041237A3 Cyclic v3 peptides for anti hiv-1 vaccine
07/15/2010WO2010040136A3 Selection of hiv vaccine antigens by use of intrapatient sequence variation to identify mutations in the hiv envelope glycoprotein that affect the binding of broadly neutralizing antibodies
07/15/2010WO2010036964A3 Modified animal erythropoietin polypeptides and their uses
07/15/2010WO2010035107A9 Peptides and compositions for prevention of cell adhesion and methods of using same
07/15/2010WO2009033282A8 Mitogen-activated protein kinase kinase kinase 14 (map3k14) polymorphisms as indicators of subject outcome in critically ill subjects
07/15/2010US20100179307 Biomaker composition for detecting diabetic retinopathy and diagnostic kit therefor
07/15/2010US20100179306 Antibodies for identifying and/or isolating at least one cell population
07/15/2010US20100179305 Protein isolation procedures for reducing phytic acid
07/15/2010US20100179304 Somatostatin-Dopamine Chimeric analogs
07/15/2010US20100179303 Site-specific conjugation of ligands to nanoparticles
07/15/2010US20100179094 Bispecific egfr/igfir binding molecules
07/15/2010US20100179093 Neoropeptide-2-Receptor (Y-2R) Agonists
07/15/2010US20100179092 Human complement c3 derivatives with cobra venom factor-like function